Linagliptin and Mesenchymal Stem Cells: A Pilot Study

NCT02442817 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Linagliptin

Sponsor

University of Nevada, Reno

Collaborators

[object Object]